|
DRUG
HEPATITIS
From professeur Yves Horsmans, service
de Gastroentérologie des Cliniques Universitaires Saint-Luc,
1200 Bruxelles.
Contact : Professeur Yves Horsmans - UCL St Luc - 10 av. Hippocrate
B-1200 Bruxelles - Belgium
Key words : Medicamenteuze hepatitis, medicament, lever, diagnose,
frequentiecijfersë,...
Back
|
|
|
|
|
MEDICINAL
HEPATITIS
INTRODUCTION
Hepatitis
owing to medicines is an inflammation of the liver provoked by taking
medicaments.
Actually, before tackling the problem of medicinal hepatitis, it is fitting
to emphasize the fact that a medicine may provoke the appearance of all
forms of liver diseases: not only a hepatitis but also a cholestasis,
a liver tumour, a steatosis (fat accumulation in the liver), a phospholipidosis
(phospholipides accumulation in the liver), a sclerosed cholangitis, a
vascular affection,
All these diseases may be provoked by taking a medicine.
This problem remains important even now, because we often consume medicaments.
Besides, hepatic toxicity still is the first cause of death owing to medicaments
and the most important reason for the withdrawal of a medicament from
the market.
Finally, in spite of the progress in the toxicological field and the scope
of the clinical studies made before commercialising, the frequency of
hepatic diseases owing to medicaments has not diminished over the years.
.
Top
FREQUENCY
At
the moment about 1 000 medicaments have been recognized as potential hepatotoxic.
However, they very rarely provoke a hepatic affection: the fact is that
when a medicine is held responsible for a toxic hepatitis with one patient
in every hundred, it is withdrawn from the market.
For the most part of the medicaments the frequency of hepatotoxicity is
situated between one patient in every 10 000 to 100 000 patients.
This frequency number explains why the risk of hepatotoxicity usually
is only recognized after it has been thrown on the market: the number
of patients included in clinical studies before putting a medicine on
the market is almost always less than 10 000.
The difficulties to establish the hepatic toxicity of a medicine also
result from the fact that the toxicity mechanisms are not very well known
yet. A lot of factors have already been mentioned: genetics, alimentation,
age, sex,
but none of them is common to all those different form
of medicinal toxicity.
Finally, and that may be the most important factor, remains the problem
of diagnosing the liver disease owing to medicine.
Returning to the subject, medicinal hepatitis, we mustn't forget that
it is necessary to distinguish between acute and chronic hepatitis: acute
hepatitis last less whereas chronic hepatitis last more than 6 months.
Top
DIAGNOSTIC
Diagnosing the hepatitis requires the following elements:
1. taking the medicine (patient may have forgotten).
2. there must be a chronic relation between the first taking of the medicine
and the appearance of the hepatitis. In most cases the delay is less than
6 months.
3. the other causes of hepatitis must be excluded: viral forms, metabolic
4. the end of the taking of the medicine must be associated with an amelioration
of the hepatic affection.
5. and finally, even though it is not necessary to have recourse to that
remedy, re-administering the medicine concerned must be associated with
a re-appearance of the hepatitis.
In practice, it is of course quite clear that these 5 elements must be
taken into account but it also is necessary to emphasize the fact that
a medicinal hepatic affection for the most part is observed among patients
more than 50 years of age and taking several medicines.
Finally, as far as allopathic medicines are concerned it is necessary
to notice that phytotherapeutic medications as well as excipientia and
chemical agents can bring about the appearance of hepatic diseases.
Top
Back
|
|